Verteporfin photodynamic therapy combined with intravitreal ranibizumab in neovascular age-related macular degeneration: 24-month follow-up

Verteporfin photodynamic therapy combined with intravitreal ranibizumab in neovascular age-related macular degeneration: 24-month follow-up

Purpose: to evaluate the efficacy and safety of combined therapy with Photodynamic Therapy with Verteporfin (PDT-V) and intravitreal ranibizumab same-day compared with monotherapy with ranibizumab (three monthly injections ) for the treatment of the choroidal neovascularization (CNV) due to age-rela...

Full description

Bibliographic Details
Main Authors: Rosalia Giustolisi, Fernanda Pacella, Olga Mastrangelo, Gabriella Cirigliano, Francesca Arienzo, Simone De Gaetano, Elena Pacella
Format: Article
Language:English
Published: Eleven Senses 2014-09-01
Series:Senses and Sciences
Subjects:
CNV
AMD
Ranibizumab
PDT
Online Access:http://www.sensesandsciences.com/#!verteporfin-photodynamic-therapy-combine/c1vny

Similar Items

Similar Items